Form EFFECT Terns Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 7, 2026 |
| Accession Number: | 0001193125-26-205352 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
- Crossbow Enterprise Cybersecurity Secures Third Consecutive PCI SSC GEAR Term (2026–2028), Bringing Nearly 12 Years of Expertise to Global Payment Security
- Voxtome Announces Dedicated LitRPG Audiobook App Built with Gamified Progression, Author-First Economics, and Precision Listening Tech
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
